Clinical Trials in San Antonio

Showing 6481-6500 of 11,125 trials

Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies

NCT02906670

This is the first study to test Sym013 (Pan-HER) in humans. The primary purpose of this study is to see if Sym013 is safe and effective for patients with advanced epithelial malignancies without available therapeutic options.

Oncology

Symphogen A/S32 participantsStarted Nov 2016

Nashville, Tennessee, United States • San Antonio, Texas, United States • San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

NCT01610284

This study was a multi-center, randomized, double-blind, placebo controlled Phase III study to determine the efficacy and safety of treatment with buparlisib plus fulvestrant versus fulvestrant plus placebo in postmenopausal women with hormone Receptor-positive (HR-positive), human epidermal growth factor receptor 2-negative (HER2-negative), locally advanced or metastatic breast cancer (MBC) whose disease has progressed on or after aromatase inhibitor (AI) treatment.

Breast Cancer

Novartis Pharmaceuticals1,147 participantsStarted Aug 2012

Mobile, Alabama, United States • Phoenix, Arizona, United States • Fayetteville, Arkansas, United States +265 more locations

Sym013 (Pan-HER) in Patients With Advanced Epithelial Malignancies

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

Find Trials by Condition in San Antonio

Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active Metabolites

Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus

Efficacy and Safety of Norketotifen in Adults With Allergic Rhinitis

Acthar Gel for Active Systemic Lupus Erythematosus (SLE)

LEO 90100 Twice Weekly Maintenance Regimen for Psoriasis Vulgaris

Study Evaluating Oral MOA-728 For The Treatment Of OIBD In Subjects With Chronic Non-Malignant Pain

Genecept Assay™ vs. Treatment-as-Usual to Evaluate Efficacy of Assay-Guided Treatment in Adults With MDD

A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung

Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis

Safety and Efficacy of IDP-122 Lotion When Applied Topically to Subjects With Moderate to Severe Plaque Psoriasis

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

AMG 827 in Subjects With Psoriatic Arthritis

Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrhoeae

Safety and Efficacy of BAY94-9027 in Previously Treated Male Children With Haemophilia A

A Study of CK-2127107 in Patients With Spinal Muscular Atrophy

Safety and Efficacy of Pimavanserin in Adults With Parkinson's Disease and Depression

Study to Evaluate the Safety and Efficacy of CTP-656 in Patients With Cystic Fibrosis With CFTR Gating Mutations

Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05